Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations

  1. Górriz, J.L.
  2. Romera, I.
  3. Cobo, A.
  4. O’Brien, P.D.
  5. Merino-Torres, J.F.
Journal:
Diabetes Therapy

ISSN: 1869-6961,  1869-6953

Year of publication: 2022

Volume: 13

Issue: 3

Pages: 389-421

Type: Review

DOI: 10.1007/S13300-021-01198-5 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus